Logos Global Management LP Tyra Biosciences, Inc. Transaction History

Logos Global Management LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$11.99 - $17.51 $669,053 - $977,075	-55,801 Reduced 63.65%	31,872 $542,000
Q1 2023 May 15, 2023	SELL	$6.85 - $16.22 $158,803 - $376,028	-23,183 Reduced 20.91%	87,673 $1.41 Million
Q4 2022 Feb 14, 2023	SELL	$5.68 - $8.81 $93,492 - $145,012	-16,460 Reduced 12.93%	110,856 $842,000
Q3 2022 Nov 14, 2022	SELL	$6.61 - $12.42 $259,178 - $486,988	-39,210 Reduced 23.55%	127,316 $1.12 Million
Q2 2022 Aug 15, 2022	SELL	$5.26 - $11.19 $453,412 - $964,578	-86,200 Reduced 34.11%	166,526 $1.19 Million
Q1 2022 May 16, 2022	SELL	$10.03 - $14.09 $2.21 Million - $3.11 Million	-220,668 Reduced 46.61%	252,726 $2.7 Million
Q4 2021 Feb 14, 2022	SELL	$12.23 - $31.35 $6.48 Million - $16.6 Million	-530,000 Reduced 52.82%	473,394 $6.66 Million
Q3 2021 Nov 15, 2021	BUY	$16.91 - $26.0 $17 Million - $26.1 Million	1,003,394 New	1,003,394 $17.7 Million

43.2M

353K

1.1K

Ticker TYRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,973,600
Market Cap $607M
Description
Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

Stay updated on Logos Global Management LP with notifications on news.